Not applicableNot Yet RecruitingNCT07645742What this trial is testingPilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWho this might be right forCancer (Advanced Stage) West Virginia University 90
Testing effectiveness (Phase 2)UnknownNCT05019794What this trial is testingInfigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR AlterationsWho this might be right forGastric CancerGastroesophageal Junction AdenocarcinomaSolid Tumor LianBio LLC 80
Early research (Phase 1)Looking for participantsNCT06873659What this trial is testingSON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorGastric CancerLiver Cancer Qurgen Inc. 96
Early research (Phase 1)Ended earlyNCT04099277What this trial is testingLY3435151 in Participants With Solid TumorsWho this might be right forSolid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more Eli Lilly and Company 2
Early research (Phase 1)Not Yet RecruitingNCT06748872What this trial is testingEPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial SarcomaWho this might be right forEpithelial Ovarian CancerGastro-esophageal Junction CancerSoft Tissue Sarcoma (STS)+2 more Medigene AG 55
Early research (Phase 1)Looking for participantsNCT07114601What this trial is testingLY4257496 in Participants With Cancer (OMNIRAY)Who this might be right forBreast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more Eli Lilly and Company 421
Testing effectiveness (Phase 2)Active Not RecruitingNCT03935893What this trial is testingAdoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersWho this might be right forGastric CancerColorectal CancerPancreatic Cancer+7 more Udai Kammula 20
Early research (Phase 1)Study completedNCT00313599What this trial is testingLapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more University of California, San Francisco 28
Early research (Phase 1)Looking for participantsNCT07358806What this trial is testingStudy to Assess the Effect of OCT-598 in Patients With Advanced Solid TumorsWho this might be right forSolid TumorBreast CancerHead and Neck Cancer+3 more Oscotec Inc. 51
Early research (Phase 1)Study completedNCT02574663What this trial is testingTGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid TumorsWho this might be right forPancreatic CancerColorectal CancerRectal Cancer+3 more TG Therapeutics, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Looking for participantsNCT06988475What this trial is testingDETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET DysregulationsWho this might be right forSolid TumourHaematological MalignancyMalignant Neoplasm+8 more Cancer Research UK 30
Early research (Phase 1)Ended earlyNCT05233436What this trial is testingPF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorsGastric CancerGastroesophageal Junction Cancer+3 more Pfizer 21
Early research (Phase 1)Active Not RecruitingNCT05239143What this trial is testingP-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsWho this might be right forBreast CancerOvarian CancerNon Small Cell Lung Cancer+6 more Poseida Therapeutics, Inc. 180
Testing effectiveness (Phase 2)UnknownNCT03789617What this trial is testingA Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive MalignanciesWho this might be right forEBV Associated Extranodal NK/T-cell LymphomaEBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma Eutilex 72
Testing effectiveness (Phase 2)Looking for participantsNCT04895709What this trial is testingBMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsWho this might be right forCervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more Bristol-Myers Squibb 1,109
Early research (Phase 1)Looking for participantsNCT07646106What this trial is testingTHE-0504 in Patients With Solid TumorsWho this might be right forSmall Cell Lung Cancer (SCLC)Colorectal Carcinoma (CRC)Gastric Cancer (GC)+2 more Thena Biotech S.r.l. 30
Early research (Phase 1)Ended earlyNCT03511222What this trial is testingVorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid TumorsWho this might be right forSolid TumorHepatocellular CarcinomaGastric Cancer+1 more Washington University School of Medicine 16
Early research (Phase 1)Study completedNCT01576666What this trial is testingPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsWho this might be right forDose EscalationSafetyPreliminary Efficacy+9 more Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Looking for participantsNCT06710756What this trial is testingLead-212 PSV359 Therapy for Patients With Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaGastric CancerEsophageal Cancer+5 more Perspective Therapeutics 112